Cary Baker - 20 Feb 2025 Form 4 Insider Report for IMPINJ INC (PI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Feb 2025, 16:34:49 UTC
Prior SEC filing
14 Jan 2025
Next SEC filing
25 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Yukio Morikubo, Attorney in fact for Cary Baker

Key filing fact

Cary Baker filed Form 4 for IMPINJ INC (PI) on 24 Feb 2025.

Key facts

  • This page summarizes Cary Baker's Form 4 filing for IMPINJ INC (PI).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Feb 2025, 16:34.

Change

  • Previous filing in this sequence was filed on 14 Jan 2025.
  • Current net transaction value: -$153,377.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PI transaction

Common Stock

Award

Transaction value
$0
Shares
+6,250
Change %
+8.7%
Price
$0.000000
Shares after
78,004
Date
20 Feb 2025
Ownership
Direct
Footnotes
F1
PI transaction

Common Stock

Sale

Transaction value
$68,575
Shares
-701
Change %
-0.9%
Price
$97.82
Shares after
77,303
Date
21 Feb 2025
Ownership
Direct
Footnotes
F2, F3
PI transaction

Common Stock

Sale

Transaction value
$23,134
Shares
-234
Change %
-0.3%
Price
$98.86
Shares after
77,069
Date
21 Feb 2025
Ownership
Direct
Footnotes
F2, F4
PI transaction

Common Stock

Sale

Transaction value
$61,668
Shares
-618
Change %
-0.8%
Price
$99.79
Shares after
76,451
Date
21 Feb 2025
Ownership
Direct
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On March 23, 2022, the Reporting Person was granted performance restricted stock units (PSUs). The PSUs vested upon the Reporting Person's satisfaction of certain performance criteria. On February 19, 2025, the Issuer's Board of Directors determined the level at which the corporate performance goals were attained, resulting in the vesting of 6,250 shares of Common Stock underlying the PSUs.

Footnote F2

These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of PSUs.

Footnote F3

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $97.20 to $98.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Footnote F4

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $98.44 to $99.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Footnote F5

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $99.68 to $99.985 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .